Raju Mohan, PhD, is currently the executive vice president of research at Alexar Therapeutics. Dr. Mohan was the founder and president of Anayaderm, a specialty dermatology company he founded in 2011 and which was acquired by Alexar in 2014. From 2001 to 2004, Dr. Mohan was the vice president of chemistry at X-Ceptor (acquired by Exelixis) and vice president and site head for Exelixis’ San Diego site from 2006 to 2010. From 1997 to 2000, he held increasingly senior positions at Berlex Biosciences, a subsidiary of Bayer/Schering AG.

Dr. Mohan is responsible for the discovery of multiple small-molecule compounds that have entered the clinic including one currently in Phase III trials. He has published extensively in peer-reviewed journals and is an inventor on 50 issued U.S. patents. Dr. Mohan received his PhD in chemistry from the University of Illinois at Urbana-Champaign and his master’s degree from the Indian Institute of Technology, Bombay, India.